Petrochemicals · Founded 1983 · www.hfl.co.in · BSE 524013 · · ISIN INE806J01013
No Notes Added Yet
Business
Hindustan Fluorocarbons Ltd. (HFL) is a fully owned subsidiary of Hindustan Organic Chemicals Limited (HOCL), a Public Sector Undertaking (PSU) under the Ministry of Chemicals and Fertilizers, Government of India. HFL is primarily engaged in the manufacturing of fluorochemicals. Its core business involves producing various fluorocarbon refrigerants and intermediates, particularly Hydrochlorofluorocarbon (HCFC) refrigerants like HCFC-22 and HCFC-142b, as well as Anhydrous Hydrochloric Acid (AHF), a crucial raw material for fluorochemical production. The company generates revenue by selling these fluorochemical products to industrial customers in sectors such as refrigeration, air conditioning, foam blowing, and specialty polymer manufacturing.
Revenue Mix
HFL primarily operates within a single business segment: fluorochemicals. Its product portfolio can be broadly categorized into:
Refrigerants: Primarily HCFCs (e.g., HCFC-22), used in air conditioning and refrigeration systems.
Specialty Chemicals/Intermediates: HCFC-22 also serves as a monomer for Polytetrafluoroethylene (PTFE), a high-performance fluoropolymer.
Raw Materials: Production of Anhydrous Hydrochloric Acid (AHF), which is used captive and may be sold externally.
Specific detailed segment-wise revenue contributions are not publicly available, but the bulk of its revenue is derived from the sale of HCFCs and related fluorochemicals.
Industry
HFL operates within the specialized and capital-intensive fluorochemicals segment of the Indian petrochemicals industry. This industry is characterized by stringent environmental regulations due to the ozone depletion potential and global warming potential of many fluorocarbons. While HFL has a historical presence as an early domestic manufacturer of fluorochemicals in India, its current market position faces challenges. It competes with larger, more diversified private players (e.g., Gujarat Fluorochemicals, SRF Limited) who have invested in newer-generation HFCs/HFOs and advanced fluoropolymers. HFL's positioning is primarily as a domestic producer focusing on the HCFC market, which is under a global phase-down schedule due to international protocols.
MOAT
HFL's competitive advantages are relatively modest:
Established Infrastructure & Technical Know-how: Decades of operational history (since 1983) have provided the company with technical expertise and established manufacturing facilities for existing fluorochemical processes.
Partial Backward Integration: Producing key raw materials like Anhydrous Hydrochloric Acid (AHF) offers some level of cost control and supply chain stability for its core products.
PSU Association: As a subsidiary of a PSU, it historically benefited from government support and policy alignment.
However, these advantages are limited by a lack of significant product diversification into next-generation, environmentally compliant chemicals, ongoing financial difficulties, and strong competition from financially robust and technologically advanced private sector players.
Growth Drivers
Potential growth drivers for HFL, contingent on strategic shifts and investment, could include:
Continued Demand for HCFC-22 as Feedstock: The sustained demand for HCFC-22 as a monomer for PTFE production could provide a stable revenue stream, even as its use as a refrigerant declines.
Transition to Next-Gen Fluorochemicals: Successful investment in research and development and manufacturing capabilities for environmentally friendly Hydrofluorocarbons (HFCs), Hydrofluoroolefins (HFOs), or advanced fluoropolymers could open new, high-growth markets.
India's Industrial and Infrastructure Growth: General economic expansion and growth in end-user industries (e.g., air conditioning, automotive, specialty plastics) could indirectly drive demand for fluorochemicals.
Government-Backed Revival Plans: Any successful implementation of government-led modernization or revival plans for HFL could provide a new impetus for growth and operational stability.
Risks
HFL faces several significant risks:
Regulatory & Environmental Risks: The ongoing global phase-down of HCFCs under the Montreal Protocol directly impacts its core product market. Strict environmental regulations necessitate continuous, substantial capital investment in new, compliant technologies.
Financial Viability & Liquidity: The company has a history of severe financial distress, including accumulated losses and eroded net worth, which poses a substantial risk to its long-term operations without significant intervention.
Intense Competition: Stiff competition from larger, more technologically advanced domestic and international players who have diversified into newer product lines.
Technological Obsolescence: The rapid evolution of fluorochemical technology, driven by environmental concerns, can quickly render existing production processes and products outdated.
Commodity Price Volatility: Fluctuations in the prices of key raw materials (e.g., Fluorspar, Chloroform) and energy costs significantly impact profitability.
Capital Intensity: The chemical industry is inherently capital-intensive, requiring continuous investment in plant upgrades, maintenance, and R&D.
Management & Ownership
Hindustan Fluorocarbons Ltd. (HFL) is a wholly-owned subsidiary of Hindustan Organic Chemicals Limited (HOCL), which is a Public Sector Undertaking (PSU) under the administrative control of the Ministry of Chemicals and Fertilizers, Government of India. Consequently, the ultimate ownership rests with the Government of India. The management of HFL is overseen by a board of directors appointed in accordance with PSU guidelines, typically comprising government nominees and functional directors. Management quality is generally aligned with public sector governance practices, focusing on operational stability and compliance, with strategic direction often guided by the parent company (HOCL) and the supervising ministry.
Outlook
HFL operates in a specialized but challenging segment of the Indian petrochemicals industry. While it possesses established infrastructure and historical expertise in fluorochemical manufacturing, its long-term outlook is heavily influenced by significant financial constraints and the imperative to adapt to evolving environmental regulations. The ongoing phase-down of HCFCs mandates a strategic shift towards newer, greener technologies, which requires substantial capital investment the company has historically struggled to secure. While there might be some residual demand for its products as chemical intermediates, sustained growth and profitability are contingent upon successful diversification, technological upgrades, and overcoming its severe financial challenges. Without clear and decisive government intervention or a major strategic overhaul, HFL faces an uncertain future in a rapidly evolving and competitive market.
| #(Fig in Cr.) | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Total Income | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Adjustments | -0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 |
| Adjusted Earnings Per Share | 0.1 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | -0.2 | 0.1 | 0.1 | -0 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 35 | 34 | 37 | 39 | 31 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income | 1 | 0 | 0 | 2 | 0 | 2 | 3 | 2 | 2 | 2 | 1 | 3 |
| Total Income | 36 | 34 | 37 | 41 | 31 | 6 | 3 | 2 | 2 | 2 | 1 | 3 |
| Total Expenditure | 42 | 33 | 34 | 35 | 32 | 28 | 8 | 7 | 1 | 2 | 1 | 1 |
| Operating Profit | -6 | 1 | 4 | 6 | -0 | -22 | -5 | -4 | 1 | 0 | 0 | 0 |
| Interest | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | -11 | -4 | -1 | 2 | -4 | -25 | -6 | -5 | 1 | 0 | 0 | 0 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | -11 | -4 | -1 | 2 | -4 | -25 | -6 | -5 | 1 | 0 | 0 | 0 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -11 | -4 | -1 | 2 | -4 | -25 | -6 | -5 | 1 | 0 | 0 | 0 |
| Adjusted Earnings Per Share | -5.7 | -2 | -0.4 | 0.9 | -1.9 | -12.7 | -3.1 | -2.6 | 0.6 | 0.2 | 0.2 | 0 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 0% | -100% | -100% |
| Operating Profit CAGR | 0% | 0% | 0% | 0% |
| PAT CAGR | 0% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 8% | 8% | 12% | 5% |
| ROE Average | 0% | 0% | 0% | 0% |
| ROCE Average | 3% | 6% | -10% | -5% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | -64 | -34 | -38 | -43 | -47 | -73 | -79 | -84 | -83 | -82 | -82 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 10 | 7 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 6 | 6 | 8 | 10 | 9 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 85 | 86 | 89 | 98 | 99 | 149 | 152 | 149 | 146 | 146 | 133 |
| Total Liabilities | 38 | 65 | 62 | 65 | 60 | 76 | 74 | 65 | 64 | 64 | 51 |
| Fixed Assets | 24 | 53 | 52 | 50 | 49 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 13 | 12 | 10 | 13 | 10 | 76 | 26 | 34 | 32 | 32 | 20 |
| Total Assets | 38 | 65 | 62 | 65 | 60 | 76 | 74 | 65 | 64 | 64 | 51 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 11 | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 0 |
| Cash Flow from Operating Activities | 4 | 2 | 0 | -1 | 0 | -68 | -2 | -15 | -2 | -3 | 1 |
| Cash Flow from Investing Activities | -5 | 0 | -0 | -0 | 0 | 0 | 2 | 17 | 0 | 3 | 1 |
| Cash Flow from Financing Activities | -9 | -3 | -1 | 1 | -0 | 68 | 1 | -1 | -0 | -0 | -3 |
| Net Cash Inflow / Outflow | -9 | -1 | -1 | -0 | -0 | 0 | 1 | 1 | -2 | -0 | -0 |
| Closing Cash & Cash Equivalent | 2 | 1 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 0 | 0 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -5.67 | -1.96 | -0.39 | 0.87 | -1.85 | -12.67 | -3.13 | -2.61 | 0.63 | 0.22 | 0.16 |
| CEPS(Rs) | -4.97 | -1.19 | 0.36 | 1.63 | -1.1 | -11.8 | -3.13 | -2.61 | 0.63 | 0.22 | 0.16 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -32.49 | -32.43 | -34.9 | -37.33 | -39.44 | -52.36 | -55.5 | -58.11 | -57.49 | -57.27 | -57.11 |
| Core EBITDA Margin(%) | -17.42 | 1.28 | 7.69 | 8.57 | -0.52 | -571.76 | 0 | 0 | 0 | 0 | 0 |
| EBIT Margin(%) | -19.33 | -1.46 | 5.09 | 10.56 | -4.42 | -553.17 | 0 | 0 | 0 | 0 | 0 |
| Pre Tax Margin(%) | -28.04 | -10.1 | -1.8 | 3.71 | -9.83 | -573.74 | 0 | 0 | 0 | 0 | 0 |
| PAT Margin (%) | -28.04 | -10.1 | -1.8 | 3.71 | -9.83 | -573.74 | 0 | 0 | 0 | 0 | 0 |
| Cash Profit Margin (%) | -24.6 | -6.1 | 1.64 | 6.97 | -5.82 | -534.59 | 0 | 0 | 0 | 0 | 0 |
| ROA(%) | -25.91 | -7.42 | -1.21 | 2.68 | -5.82 | -36.47 | -8.2 | -7.36 | 1.9 | 0.66 | 0.54 |
| ROE(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| ROCE(%) | 0 | 0 | 0 | 0 | 0 | 0 | -32.02 | -36.15 | 11.83 | 3.79 | 3.08 |
| Receivable days | 24.32 | 30.47 | 32.9 | 34.99 | 47.63 | 247.28 | 0 | 0 | 0 | 0 | 0 |
| Inventory Days | 77.06 | 61.26 | 45.55 | 43.67 | 48.12 | 288.04 | 0 | 0 | 0 | 0 | 0 |
| Payable days | 88.58 | 93.68 | 87.57 | 91.48 | 72.45 | 159.53 | 2193.13 | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 17.68 | 0 | 0 | 0 | 0 | 25.92 | 57.78 | 0 |
| Price/Book(x) | -0.17 | -0.53 | -0.3 | -0.41 | -0.07 | -0.14 | -0.17 | -0.15 | -0.28 | -0.22 | 0 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.76 | 2.31 | 1.83 | 2.11 | 1.87 | 37.08 | 0 | 0 | 0 | 0 | 0 |
| EV/Core EBITDA(x) | -9.88 | 80.76 | 18.39 | 12.93 | -391.78 | -6.12 | -22.36 | -24.76 | 104.43 | 281.46 | 397.15 |
| Net Sales Growth(%) | 21.01 | -4.08 | 8.92 | 5.45 | -19.39 | -88.29 | -99.91 | -100 | 0 | 0 | 0 |
| EBIT Growth(%) | -356.24 | 92.75 | 495.23 | 120.81 | -133.71 | -1366.51 | 77.43 | 17.57 | 127.56 | -65.39 | -26.46 |
| PAT Growth(%) | -194.44 | 65.4 | 79.88 | 319.93 | -313.42 | -583.59 | 75.32 | 16.57 | 124 | -65.39 | -26.47 |
| EPS Growth(%) | -194.44 | 65.4 | 79.88 | 319.92 | -313.43 | -583.58 | 75.32 | 16.57 | 124 | -65.39 | -26.49 |
| Debt/Equity(x) | -0.84 | -0.72 | -0.68 | -0.71 | -0.68 | -1.18 | -1.14 | -1.09 | -1.1 | -1.1 | -1.08 |
| Current Ratio(x) | 0.15 | 0.14 | 0.11 | 0.14 | 0.1 | 0.51 | 0.17 | 0.23 | 0.22 | 0.22 | 0.15 |
| Quick Ratio(x) | 0.07 | 0.07 | 0.05 | 0.08 | 0.06 | 0.49 | 0.16 | 0.23 | 0.22 | 0.22 | 0.15 |
| Interest Cover(x) | -2.22 | -0.17 | 0.74 | 1.54 | -0.82 | -26.89 | -7.44 | -6.75 | 0 | 4248 | 3124 |
| Total Debt/Mcap(x) | 4.8 | 1.37 | 2.25 | 1.72 | 9.2 | 8.22 | 6.59 | 7.08 | 3.89 | 5.04 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 63.85 | 72.43 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| Public | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 35.65 | 27.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.25 | 1.42 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.7 | 0.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | — | — | -100% | -100% |
| Operating Profit CAGR | — | — | — | — |
| PAT CAGR | — | — | — | — |
| Share Price CAGR | +8% | +8% | +12% | +5% |
| ROE Average | 0% | 0% | 0% | 0% |
| ROCE Average | +3% | +6% | -10% | -5% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 60.87 | 63.85 | 72.43 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 |
| Public | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 38.62 | 35.65 | 27.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.19 | 1.25 | 1.42 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Public | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.76 | 0.7 | 0.53 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 | 1.96 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.